Zdrowie i gospodarka · 03/06/1998

FDA Classifies Immunohistochemistry Reagents and Kits into Three Classes Based on Intended Use

The FDA is issuing a final rule to categorize immunohistochemistry reagents and kits into three classes, with some devices exempt from premarket notification requirements due to low risk to public health, while others require premarket approval.